Based on the given data, Denmark’s mortality rate from malignant neoplasms stands at 221.1 deaths per hundred thousand persons in 2024. This is forecasted to decrease year-on-year by approximately -1.1% to 218.6 in 2025, further dropping by -1.2% to 216.0 in 2026, -1.2% to 213.4 in 2027, and -1.2% to 210.9 in 2028. These reflect a consistent downward trend in mortality rates, which could be attributed to ongoing advancements in medical treatments, early detection, and improved healthcare initiatives.

The compound annual growth rate (CAGR) over the five-year forecast period from 2024 to 2028 projects an average annual decline of around -1.2% in the mortality rate from malignant neoplasms.

Future trends to watch for include:

Continued medical advancements and innovations in cancer treatments and therapies.
Further improvements in early detection and preventive healthcare measures.
Impact of public health policies and awareness programs targeting cancer prevention.
Potential demographic shifts and their effects on cancer mortality rates.